April 25th 2025
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
Infused Chemotherapy Use in the Elderly After Patent Expiration
As calls for improving the quality and cost efficiency of oncology increase, future empirical work is needed to examine the responsiveness of oncologists' treatment decision making to incentives among patients of all ages and insurance types.
Read More
Care by Cell Phone: Text Messaging for Chronic Disease Management
Cell phone“based text messaging may be used to feasibly support chronic disease management and engagement in diabetes self-care behaviors for some patients.
Read More